U.S., Aug. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07099001) titled 'Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay' on July 16.
Brief Summary: This is a national-level research study of neurologists and dementia specialists. The purpose of this study is to assess the clinical evaluation and management recommendations made by practicing providers for patient simulations with symptoms of cognitive decline.
Study Start Date: July 31
Study Type: INTERVENTIONAL
Condition:
Alzheimer Disease (AD)
Cognitive Decline
Intervention:
OTHER: Educational materials on the Alzheimer's disease assay
Between Round 1 and Round 2 virtual patient case administrati...